Cart
×
AFFINITY DUCHENNE: New Phase 1/2 Interim Functional Data
Please join CureDuchenne and REGENXBIO on Wednesday, June 11 at 1 p.m. E.T. for a community webinar, “RGX-202: AFFINITY DUCHENNE: New Phase 1/2 Interim Functional Data – June 2025”.
Dr. Naz Dastgir will provide an update and share new interim clinical data from the Phase 1/2 portion of its ongoing AFFINITY DUCHENNE study of RGX-202, an investigational microdystrophin gene therapy.
June 11, 2025 | 10 AM Pacific | 1 PM Eastern